SAN DIEGO, April 19, 2001 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) said that on Tuesday, April 24, 2001 the Company will release its financial results for the first quarter and three months ended March 31, 2001. Edward F. Calesa, chairman, president and CEO, and Charles M. Caporale, vice president and CFO, will host a conference call that same day at 11 a.m. Eastern Time (8 a.m. Pacific Time) to discuss the Company's financial results. Discussions may contain forward-looking and other material information.
Access Instructions:
The April conference call will be available to all interested parties through a live audio Web broadcast via the Internet at Women First's Website, www.womenfirst.com, and at www.streetfusion.com.
Replay Option Available Until May 8, 2001:
Audio-only via Internet: The call will be archived and available on the above Websites for two weeks beginning 1 p.m., EST, Tuesday, April 24, through 5 p.m., EST, Tuesday, May 8.
Audio-only via Telephone: A telephone replay of the call will also be available from 1 p.m., EST, Tuesday, April 24, through 5 p.m., EST, Tuesday, May 8. Please call (888) 203-1112 (domestic) or (719) 457-0820 (international) and use access code No. 760830.
For further information please contact Charles M. Caporale, vice president and CFO, Women First HealthCare, Inc., (858) 509-3806, ccaporale@womenfirst.com; or Diane Donohue, Manager, Public Relations, Women First HealthCare, Inc., (858) 509-3860, ddonohue@womenfirst.com.
About Women First HealthCare, Inc.
Founded in 1996, Women First HealthCare, Inc. is a San Diego-based specialty pharmaceutical company. Its mission is to help midlife women make informed choices regarding their health care needs and to provide pharmaceutical and lifestyle products to meet those needs. Women First is specifically targeted to women age 40+ and their clinicians. The Company's Pharmaceutical Division, which includes a nationwide team of experienced sales specialists, contacts primarily OB/GYNs and Nurse Practitioners with estrogen replenishment options-ORTHO-EST(R) Tablets and Esclim(TM) (estradiol transdermal system). The Consumer Business is responsible for Daily Difference(TM) dietary supplements, developed in consultation with Tufts University School of Nutrition Science and Policy, and the Company's line of self-care products available through its As We Change(R) national mail order catalog and Internet retailer, www.aswechange.com. Trialogue(TM), the Corporate Marketing Division, is responsible for providing access to Women First's network of opinion leaders and clinicians through strategic marketing programs for sale to major pharmaceutical companies. The Company's business strategy includes the acquisition and licensing of additional prescription products that support its mission. Further information about Women First can be found online at www.womenfirst.com.